Research peptide · TH9507
Tesamorelin
Tesamorelin 10-20mg lyophilized, GHRH analog research peptide. ≥99% HPLC purity, batch-traceable, CoA included. In stock for fast EU and worldwide shipping.
Research peptide · TH9507
Tesamorelin 10-20mg lyophilized, GHRH analog research peptide. ≥99% HPLC purity, batch-traceable, CoA included. In stock for fast EU and worldwide shipping.
Research peptide · TH9507
Tesamorelin 10-20mg lyophilized, GHRH analog research peptide. ≥99% HPLC purity, batch-traceable, CoA included. In stock for fast EU and worldwide shipping.
No reviews yet. Be the first to share your experience.
No reviews yet. Be the first to share your experience.
/ vial
Order today → Delivery Mon, Oct 12 – Tue, Oct 20 to United States
Payment Methods
/ vial
Order today → Delivery Mon, Oct 12 – Tue, Oct 20 to United States
Payment Methods
Independently verified quality
3,000+
satisfied researchers
99.43%
Avg. purity 2026
4.8 ★
ProvenExpert
99.43%
Avg. purity 2026
4.8 ★
ProvenExpert
3,000+ satisfied researchers
Tesamorelin 10mg - 1 Pack vial + 2 ml BAC water → concentration:
Per unit (10 IU)
1.00 mg
Scientific references
Research details
Tesamorelin (research code TH9507, marketed as Egrifta) is a synthetic growth hormone-releasing hormone (GHRH) analog comprising all 44 amino acids of endogenous human GHRH, enhanced with a trans-3-hexenoic acid modification at the N-terminus for improved receptor binding affinity and metabolic stability. It holds the unique distinction of being the first and only FDA-approved GHRH analog (approved in 2010) for the targeted reduction of excess abdominal fat associated with HIV-related lipodystrophy. This landmark regulatory approval, based on rigorous Phase III clinical data, underscores its exceptional safety and efficacy profile and sets Tesamorelin apart from other peptides in the growth hormone secretagogue class.
The clinical efficacy of Tesamorelin has been comprehensively validated in multiple large-scale, randomized, double-blind, placebo-controlled trials. The pivotal studies by Falutz et al., published in the Journal of Clinical Endocrinology & Metabolism (JCEM), demonstrated remarkable outcomes over treatment periods of 26 to 52 weeks:
At Bergdorf Bioscience, Tesamorelin is supplied as a high-purity, lyophilized (freeze-dried) powder. This sophisticated manufacturing process extracts moisture from the peptide, ensuring maximum chemical stability and an exceptionally long shelf life, even at room temperature.
When you buy Tesamorelin for your laboratory, you need absolute reliability. To guarantee maximum flexibility for diverse research protocols and dose-finding studies, Tesamorelin is available at Bergdorf Bioscience in two precisely defined dosages:
Each vial is filled under the strictest laboratory conditions and individually sealed. All batches are analyzed using High-Performance Liquid Chromatography (HPLC) and feature a guaranteed purity of at least 99%. Our uncompromising quality assurance also includes detailed mass spectrometry to confirm the exact molecular weight, as well as rigorous endotoxin testing.
We offer reliable worldwide shipping for all our research peptides. Thanks to professional lyophilization, the Tesamorelin powder is highly temperature-stable in its unmixed state. The molecular integrity and high biological activity of the peptide are fully preserved at normal ambient temperatures throughout global transit. However, after reconstitution (mixing with bacteriostatic water), we highly recommend proper storage in a refrigerator.
GHRH receptor agonist; stimulates pulsatile GH release; reduces visceral adipose tissue; improves triglyceride levels.
Advanced protocol
1-2 mg/days (research context)
Note: The dosages listed correspond to typical ranges from published research literature. They do not replace advice from a qualified researcher or physician.
Every batch is analyzed by an independent laboratory via HPLC before shipment. We document purity (avg. 99.43% in 2026), mass spectrometry identity, and sterility. Production follows GMP standards in ISO-certified laboratories.
Tesamorelin is a synthetic GHRH analog made of 44 amino acids, FDA-approved as Egrifta for the reduction of visceral abdominal fat.
Independently verified quality
3,000+
satisfied researchers
99.43%
Avg. purity 2026
4.8 ★
ProvenExpert
99.43%
Avg. purity 2026
4.8 ★
ProvenExpert
3,000+ satisfied researchers
Tesamorelin 10mg - 1 Pack vial + 2 ml BAC water → concentration:
Per unit (10 IU)
1.00 mg
Scientific references
Research details
Tesamorelin (research code TH9507, marketed as Egrifta) is a synthetic growth hormone-releasing hormone (GHRH) analog comprising all 44 amino acids of endogenous human GHRH, enhanced with a trans-3-hexenoic acid modification at the N-terminus for improved receptor binding affinity and metabolic stability. It holds the unique distinction of being the first and only FDA-approved GHRH analog (approved in 2010) for the targeted reduction of excess abdominal fat associated with HIV-related lipodystrophy. This landmark regulatory approval, based on rigorous Phase III clinical data, underscores its exceptional safety and efficacy profile and sets Tesamorelin apart from other peptides in the growth hormone secretagogue class.
The clinical efficacy of Tesamorelin has been comprehensively validated in multiple large-scale, randomized, double-blind, placebo-controlled trials. The pivotal studies by Falutz et al., published in the Journal of Clinical Endocrinology & Metabolism (JCEM), demonstrated remarkable outcomes over treatment periods of 26 to 52 weeks:
At Bergdorf Bioscience, Tesamorelin is supplied as a high-purity, lyophilized (freeze-dried) powder. This sophisticated manufacturing process extracts moisture from the peptide, ensuring maximum chemical stability and an exceptionally long shelf life, even at room temperature.
When you buy Tesamorelin for your laboratory, you need absolute reliability. To guarantee maximum flexibility for diverse research protocols and dose-finding studies, Tesamorelin is available at Bergdorf Bioscience in two precisely defined dosages:
Each vial is filled under the strictest laboratory conditions and individually sealed. All batches are analyzed using High-Performance Liquid Chromatography (HPLC) and feature a guaranteed purity of at least 99%. Our uncompromising quality assurance also includes detailed mass spectrometry to confirm the exact molecular weight, as well as rigorous endotoxin testing.
We offer reliable worldwide shipping for all our research peptides. Thanks to professional lyophilization, the Tesamorelin powder is highly temperature-stable in its unmixed state. The molecular integrity and high biological activity of the peptide are fully preserved at normal ambient temperatures throughout global transit. However, after reconstitution (mixing with bacteriostatic water), we highly recommend proper storage in a refrigerator.
GHRH receptor agonist; stimulates pulsatile GH release; reduces visceral adipose tissue; improves triglyceride levels.
Advanced protocol
1-2 mg/days (research context)
Note: The dosages listed correspond to typical ranges from published research literature. They do not replace advice from a qualified researcher or physician.
Every batch is analyzed by an independent laboratory via HPLC before shipment. We document purity (avg. 99.43% in 2026), mass spectrometry identity, and sterility. Production follows GMP standards in ISO-certified laboratories.
Tesamorelin is a synthetic GHRH analog made of 44 amino acids, FDA-approved as Egrifta for the reduction of visceral abdominal fat.
